Three Novel Heterozygous COL4A4 Mutations Result in Three Different Collagen Type IV Kidney Disease Phenotypes

Thin basement membrane nephropathy (TBMN), autosomal dominant Alport syndrome (ADAS), and focal segmental glomerulosclerosis (FSGS) are kidney diseases that differ in clinical diagnosis, treatment, and prognosis. Nevertheless, they may result from the same causative genes. Here, we report 3 COL4A4 heterozygous mutations (p.Gly208Arg, p.Ser513Glufs*2, and p.Met1617Cysfs*39) that lead to 3 different collagen type IV kidney disease phenotypes, manifesting as TBMN, ADAS, and FSGS. Using bioinformatics analyses and pedigree verification, we show that these novel variants are pathogenetic and cosegregate with TBMN, ADAS, and FSGS. Furthermore, we found that the collagen type IV-associated kidney disease phenotypes are heterogeneous, with overlapping pathology and genetic mutations. We propose that COL4A4-associated TBMN, ADAS, and FSGS should be considered as collagen type IV kidney disease subtypes that represent different phases of disease progression.

[1]  Asan,et al.  Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome , 2017, PloS one.

[2]  K. Nakanishi,et al.  Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[3]  H. Deng,et al.  A novel heterozygous COL4A4 missense mutation in a Chinese family with focal segmental glomerulosclerosis , 2016, Journal of cellular and molecular medicine.

[4]  E. Seaby,et al.  Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Shiguo Liu,et al.  A Novel COL4A4 Mutation Identified in a Chinese Family with Thin Basement Membrane Nephropathy , 2016, Scientific Reports.

[6]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[7]  K. Voskarides,et al.  Frequency of COL4A3/COL4A4 Mutations amongst Families Segregating Glomerular Microscopic Hematuria and Evidence for Activation of the Unfolded Protein Response. Focal and Segmental Glomerulosclerosis Is a Frequent Development during Ageing , 2014, PloS one.

[8]  G. Mollet,et al.  A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS. , 2014, Journal of the American Society of Nephrology : JASN.

[9]  G. Genovese,et al.  Mutations in PAX2 associate with adult-onset FSGS. , 2014, Journal of the American Society of Nephrology : JASN.

[10]  A. Adeyemo,et al.  Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis , 2014, Kidney international.

[11]  D. Rubel,et al.  Alport syndrome—insights from basic and clinical research , 2013, Nature Reviews Nephrology.

[12]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[13]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[14]  M. Haas.  Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. , 2009, Archives of pathology & laboratory medicine.

[15]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[16]  A. Amoroso,et al.  Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  A. Vizjak,et al.  Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome. , 2008, Srpski arhiv za celokupno lekarstvo.

[18]  J. Savige,et al.  The genetics of thin basement membrane nephropathy. , 2005, Seminars in nephrology.

[19]  P. van Paassen,et al.  Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. , 2004, Kidney international.

[20]  X. Lens,et al.  Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[22]  J. Savige,et al.  Haematuria in asymptomatic individuals , 2001, British medical journal.

[23]  L. Truong,et al.  Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  Y. Pirson.  Making the diagnosis of Alport's syndrome. , 1999, Kidney international.

[25]  H. Smeets,et al.  Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  P. D. de Leeuw,et al.  Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure. , 1997, Kidney international.

[27]  N. Daskalakis,et al.  Unexpected role of TRPC6 channel in familial nephrotic syndrome: does it have clinical implications? , 2006, Journal of the American Society of Nephrology : JASN.

[28]  V. Parsons,et al.  Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults. , 1985, American journal of nephrology.